Researchers at the Memorial Sloan Kettering Cancer Center in New York sought to discover whether or not increases in colon cancer screening rates over the last few decades have had a real impact on incidence and mortality. The results of the study were astounding.
Colorectal cancer incidence and mortality declined more than 40 percent from 1975-2011. Using randomized controlled trials and observational studies, the researchers observed the long-term effects of several different screening modalities to examine the overall impact of screening of this secular trend.
After assessing past trends of screening in the United States, the lead researchers determined that more than 50 percent of the decline in colon cancer incidence and mortality can be attributed to increased acceptance and uptake in colon cancer screening.
Screening has and will continue to have a major impact on the reduction of colon cancer incidence and mortality. The next step is to take measures to understand the ways to achieve the highest impact on colon cancer incidence and mortality, and implement programs designed to further reduce the burden of this disease.
Moral of the story? Be Seen, Get Screened!
Other News From Around the Web
- What will GI practice look like 10 years from now? Gastroenterologists speculate about the future of their speciality.
- Research suggests that the "ick" factor is the primary deterrent when it comes to screening colonoscopy.
- A new study found that the next generation of prescription diet pills may play a role in increasing colon cancer risk.
- Here's an article that discusses whether or not genetic tests are clinically useful when it comes to colorectal cancer.